Pyelonephritis

Upper UTI/Pyelonephritis

Pyelonephritis is a bacterial infection of the renal pelvis and renal parenchyma causing inflammation of the kidney. It represents the upper spectrum of urinary tract infection (UTI).


Acute Pyelonephritis

Acute suppurative bacterial infection involving:

  • Renal pelvis/Collecting system/Renal interstitium/Renal tubules

Usually occurs due to:

  • Ascending infection from lower urinary tract
  • Less commonly hematogenous spread

Chronic Pyelonephritis

Chronic tubulointerstitial inflammation and scarring due to:

  • Recurrent pyelonephritis/Vesicoureteral reflux/Chronic obstruction

Leads to:Renal scarring/Tubular atrophy/CKD/Hypertension


Risk Factors

Anatomical Factors

Functional Factors

Behavioral Factors

Vesicoureteral reflux

Pregnancy

Frequent intercourse

Urinary obstruction

Diabetes mellitus

Spermicide use

Benign prostatic hyperplasia (BPH)

Immunosuppression

Poor hydration

Ureteric stone

Chronic kidney disease (CKD)


Pelviureteric junction (PUJ) obstruction

Catheterization


Neurogenic bladder

Urinary tract instrumentation


Congenital urinary tract anomalies

Urinary retention


Etiology 

Organism

Comments

Escherichia coli

Most common (~70–90%)

Klebsiella pneumoniae

Common in healthcare-associated infection

Proteus mirabilis

Associated with struvite stones

Enterococcus faecalis

Elderly/catheterized

Pseudomonas aeruginosa

Instrumentation, ICU

Staphylococcus saprophyticus

Young women

Candida albicans

Catheterized/immunocompromised

Routes of Infection

1. Ascending Infection (Most Common)

Pathogenesis:

  1. Colonization of periurethral area
  2. Ascending cystitis
  3. Vesicoureteral reflux
  4. Intrarenal reflux
  5. Renal infection


2. Hematogenous Spread

Less common.Seen with:

  • Staphylococcus aureus bacteremia/Endocarditis
  • IV drug abuse/Immunosuppression

Classification

Feature

Acute Pyelonephritis (APN)

Xanthogranulomatous Pyelonephritis (XGP)

Emphysematous Pyelonephritis (EPN)

Definition

Acute bacterial infection of renal pelvis and parenchyma

Rare chronic destructive granulomatous renal infection with replacement of renal tissue by lipid-laden macrophages

Necrotizing renal infection characterized by gas formation within kidney and/or surrounding tissues

Typical Organism

E. coli (most common)

Proteus mirabilis, E. coli

E. coli (60–70%), Klebsiella, Proteus

Pathogenesis

Ascending UTI renal infection

Chronic obstruction + recurrent infection granulomatous destruction

Gas-producing organisms ferment glucose causing tissue necrosis and gas formation

Underlying Mechanism

Acute bacterial inflammation

Lipid-laden macrophage infiltration (“xanthoma cells”)

Necrosis + gas production in renal tissues

Most Important Risk Factor

Female sex

Staghorn calculus

Diabetes mellitus

Radiology

Striated nephrogram

Bear Paw Sign

Gas within renal parenchyma

Treatment

Antibiotics ± drainage if obstructed

Nephrectomy after infection control

ICU care + carbapenem-based antibiotics(2–3 weeks minimum) + DJ stent/PCN + percutaneous drainage; nephrectomy only if treatment fails

Clinical Features

Classic Triad

  1. Fever
  2. Flank pain
  3. Nausea/vomiting

Symptoms

Symptom

Mechanism

Fever with chills

Systemic inflammation

Flank pain

Renal capsule distension

Dysuria

Associated cystitis

Frequency

Lower UTI

Urgency

Bladder irritation

Nausea/vomiting

Cytokine response

Malaise

Systemic illness

Hematuria

Mucosal inflammation

Physical Examination

Finding

Significance

Fever

Infection

Tachycardia

Sepsis

Hypotension

Septic shock

CVA tenderness

Renal inflammation

Suprapubic tenderness

Cystitis

Delirium

Elderly sepsis

Special Presentations

Elderly

May present with:

  • Delirium
  • Weakness
  • Falls
  • Sepsis without urinary symptoms

Pregnancy

Risk:

  • Preterm labor
  • ARDS
  • Sepsis

Usually due to:

  • Progesterone-mediated ureteric dilation
  • Urinary stasis


Diabetics

Higher risk of:

  • Emphysematous pyelonephritis
  • Papillary necrosis
  • Renal abscess

Diagnosis

Urinalysis

Finding

Significance

Pyuria

Hallmark

Leukocyte esterase

WBCs

Nitrite positive

Gram-negative bacteria

WBC casts

Suggest upper UTI

Mild proteinuria

Tubular inflammation

Hematuria

Inflammation

Urine Culture (Before Antibiotics)

Diagnostic Thresholds

Specimen

Significant Growth

Midstream urine

≥10⁵ CFU/mL

Symptomatic women

≥10³ CFU/mL may be significant

Catheter specimen

≥10²–10³ CFU/mL

Blood Tests

Investigation

Findings

CBC

Leukocytosis

CRP/ESR

Elevated

Procalcitonin

May correlate with severity

Renal function

AKI

Electrolytes

Sepsis-associated changes

Lactate

Severe sepsis

Blood Cultures

Positive in:15–30%

Indications:Sepsis/ICU/Immunocompromised/Severe pyelonephritis


Imaging(Diagnosis can often be made clinically without imaging.)

Ultrasound

Useful for:Hydronephrosis/Obstruction/Abscess/Stones


CECT Abdomen/Pelvis (Best Imaging)

Indications:

  • Severe illness
  • Persistent fever >48–72 h
  • Suspected obstruction
  • AKI
  • Diabetes
  • Immunocompromised
  • Recurrent pyelonephritis

MRI

Alternative when:Pregnancy/Contrast contraindicated


Differential Diagnosis

Condition

Distinguishing Features

Renal colic

Colicky pain, no fever

Appendicitis

RLQ pain

Cholecystitis

RUQ pain

PID

Pelvic findings

Renal abscess

Persistent fever

Perinephric abscess

Toxic appearance

Glomerulonephritis

RBC casts

Lower UTI

No flank pain/fever

Complications

Local Complications

Complication

Description

Renal abscess

Localized pus collection

Perinephric abscess

Extension outside kidney

Papillary necrosis

Seen in diabetes

Emphysematous pyelonephritis

Gas-forming infection

Pyonephrosis

Infected obstructed kidney

Systemic Complications

Complication

Description

Sepsis

Systemic inflammatory response

Septic shock

Vasopressor-requiring hypotension

AKI

Sepsis + tubular injury

ARDS

Severe inflammatory response

DIC

Severe sepsis

Management

Uncomplicated Pyelonephritis (Outpatient)-Oral Options

Drug

Typical Regimen

Ciprofloxacin

500 mg BD 7 days

Levofloxacin

750 mg OD 5 days

TMP-SMX

If susceptible known then-160/800 mg PO BD for 14 days

Oral beta-lactams

Less effective than fluoroquinolones.

Oral Beta-Lactams

Drug

Dose

Amoxicillin-Clavulanate

875/125 mg BD

Cefpodoxime

200 mg BD

Cefixime

400 mg OD

Duration:10–14 days

If Local Fluoroquinolone Resistance >10%

Give a single IV long-acting agent first:

Initial Dose

Then Oral Therapy

Ceftriaxone 1 g IV once

Ciprofloxacin/Levofloxacin

Gentamicin 5–7 mg/kg IV once

Oral regimen

Amikacin 15 mg/kg IV once

Oral regimen

This is specifically recommended in IDSA guidance.


Hospitalized Patients(NO SEPTIC SHOCK)-IV Antibiotics

Antibiotic

Uses

Ceftriaxone 1–2 g IV OD

Common empiric therapy,Community-acquired APN

Piperacillin-tazobactam-4.5 g IV q6h

Complicated infection,Hospital-acquired risk,Pseudomonas

Cefepime-2 g IV q8h

Hospital-acquired infection

Carbapenem

ESBL organisms

Aminoglycosides

Severe gram-negative infection

ICU/Septic Shock

Empiric therapy should cover:

  • ESBL organisms
  • Pseudomonas aeruginosa if risk factors
  • Resistant gram-negatives

Examples:

  • Meropenem
  • Piperacillin-tazobactam + amikacin
  • Cefepime + aminoglycoside

Pregnancy

Preferred:

Drug

Dose

Ceftriaxone

1–2 g IV OD

Cefotaxime

2 g IV q8h

Amoxicillin-Clavulanate

Step-down therapy

Duration:10–14 days

Avoid:

  • Fluoroquinolones
  • Tetracyclines

Duration of Therapy

Situation

Duration

Uncomplicated

5–7 days (fluoroquinolone)

Complicated

10–14 days

Abscess

2–4 weeks

Bacteremia

Usually 10–14 days

Source Control

Urgent Urological Intervention Needed In:

  • Obstructive pyelonephritis
  • Pyonephrosis
  • Infected stone
  • Hydronephrosis with sepsis

Methods:

  • Percutaneous nephrostomy
  • Ureteric stenting

This is a urological emergency.


Suppurative Upper UTI

Feature

Corticomedullary Abscess

Renal Carbuncle(Renal Cortical Abscess)

Pyonephrosis

Definition

Intrarenal abscess involving cortex and medulla

Large cortical abscess produced by hematogenous infection with tissue necrosis

Suppurative infection within an obstructed collecting system causing pus-filled hydronephrosis

Alternative Name

Intrarenal abscess

Renal carbuncle

Infected hydronephrosis

Location

Cortex + medulla

Cortex

Pelvicalyceal system

Primary Pathogenesis

Ascending UTI

Hematogenous spread

Obstruction + infection

Typical Organism

Gram-negative bacilli

S. aureus

E. coli, Klebsiella, Proteus, Pseudomonas

Relation to UTI

Usually present

Usually absent

Always present

Surgical Emergency

Sometimes

Sometimes

Always

Main Treatment

Antibiotics(2–6 weeks) + drainage

    • <3 cm-IV antibiotics
  • ≥3–5 cm-Percutaneous drainage


Antibiotics(4–6 weeks) ± drainage

  • Small (<3 cm)

IV antibiotics alone

  • Large (>3–5 cm)

Percutaneous drainage


Urgent decompression


Perinephric Abscess vs Paranephric Abscess 

These are severe complications of upper urinary tract infection. The distinction is based primarily on anatomical location relative to Gerota’s fascia and the kidney.


Retroperitoneal Compartments

Space

Boundaries

Contents

Perinephric (Perirenal) Space

Between kidney capsule and Gerota’s fascia

Kidney, adrenal gland, perirenal fat

Paranephric (Pararenal) Space

Outside Gerota’s fascia

Fat and retroperitoneal tissues


Feature

Perinephric Abscess

Paranephric Abscess

Definition

Collection of pus within perinephric space

Collection of pus extending outside Gerota’s fascia into pararenal space

Organ Involvement

Kidney primarily

Kidney + surrounding retroperitoneum

Spread

Limited by Gerota fascia

No fascial containment

Pathogenesis

Perinephric Abscess

Route 1 (Most Common)

Ascending UTI —>Acute Pyelonephritis—>Intrarenal Corticomedullary Abscess—>Rupture Through Renal Capsule—>Perinephric Abscess

Route 2

Hematogenous spread—>Renal cortical abscess—>Extension into perinephric fat —>Perinephric abscess


Paranephric Abscess

Pyelonephritis—>Renal Abscess—>Perinephric Abscess

—>Breakthrough Gerota Fascia—>Paranephric Abscess—>Retroperitoneal Spread—>Psoas/Abdominal Wall/Subphrenic Extension


Leave a Comment

Your email address will not be published. Required fields are marked *